Devonian Health Group (TSXV:GSD) Debt-to-Equity : 0.16 (As of Oct. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Debt-to-Equity?

Devonian Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was C$2.16 Mil. Devonian Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was C$0.11 Mil. Devonian Health Group's Total Stockholders Equity for the quarter that ended in Oct. 2024 was C$14.50 Mil. Devonian Health Group's debt to equity for the quarter that ended in Oct. 2024 was 0.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Devonian Health Group's Debt-to-Equity or its related term are showing as below:

TSXV:GSD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.36 Max: 0.7
Current: 0.16

During the past 11 years, the highest Debt-to-Equity Ratio of Devonian Health Group was 0.70. The lowest was 0.01. And the median was 0.36.

TSXV:GSD's Debt-to-Equity is ranked worse than
51.33% of 1013 companies
in the Biotechnology industry
Industry Median: 0.14 vs TSXV:GSD: 0.16

Devonian Health Group Debt-to-Equity Historical Data

The historical data trend for Devonian Health Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Debt-to-Equity Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Debt-to-Equity

Get a 7-Day Free Trial

0.50

0.70

0.26

0.16

Devonian Health Group Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Debt-to-Equity	Get a 7-Day Free Trial															0.26	0.01	0.16	0.16	0.16

Competitive Comparison of Devonian Health Group's Debt-to-Equity

For the Biotechnology subindustry, Devonian Health Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Debt-to-Equity falls into.

Devonian Health Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Devonian Health Group's Debt to Equity Ratio for the fiscal year that ended in Jul. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.12	+	0.126)	/	14.462
	=	0.16

Devonian Health Group's Debt to Equity Ratio for the quarter that ended in Oct. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.157	+	0.114)	/	14.496
	=	0.16

Devonian Health Group (TSXV:GSD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Devonian Health Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines